What does DR. MANUEL VALCKE - ANESTHESIST do?

DR. MANUEL VALCKE - ANESTHESIST is a specialist medical practice in Sint-Lievens-Houtem. Private Limited, started on 1 March 2019, 1 establishment.

What is the address of DR. MANUEL VALCKE - ANESTHESIST?

The registered office of DR. MANUEL VALCKE - ANESTHESIST is located at Paardemarkt 21, 9520 Sint-Lievens-Houtem.

Is DR. MANUEL VALCKE - ANESTHESIST still active?

Yes. According to the CBE (16 September 2026) DR. MANUEL VALCKE - ANESTHESIST is active, legal situation “Normale toestand”, started on 1 March 2019.

Is DR. MANUEL VALCKE - ANESTHESIST registered on Peppol?

Yes, DR. MANUEL VALCKE - ANESTHESIST is registered on the Peppol network with ID 0208:0721753838.

What is the enterprise number of DR. MANUEL VALCKE - ANESTHESIST?

The enterprise number of DR. MANUEL VALCKE - ANESTHESIST is BE0721753838.

When was DR. MANUEL VALCKE - ANESTHESIST founded?

DR. MANUEL VALCKE - ANESTHESIST was founded on 1 March 2019.

Who are the directors of DR. MANUEL VALCKE - ANESTHESIST?

According to the 2025 annual accounts, the directors of DR. MANUEL VALCKE - ANESTHESIST are: MANUEL VALCKE.

Is DR. MANUEL VALCKE - ANESTHESIST a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 March 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. MANUEL VALCKE - ANESTHESIST make in 2025?

DR. MANUEL VALCKE - ANESTHESIST posted a profit after taxes of € 288,573 in financial year 2025.

What is the revenue of DR. MANUEL VALCKE - ANESTHESIST?

As a small company, DR. MANUEL VALCKE - ANESTHESIST is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 459,953.

DR. MANUEL VALCKE - ANESTHESIST (Private Limited)

Dossier DR. MANUEL VALCKE - ANESTHESIST, printed on 16 September 2026 from databakkes.be/en/0721753838/dr-manuel-valcke-anesthesist. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. MANUEL VALCKE - ANESTHESIST from Sint-Lievens-Houtem, company number BE0721753838, closed financial year 2025 with a result of € 288,573 after tax. For that financial year DR. MANUEL VALCKE - ANESTHESIST recorded a gross margin of € 459,953 and equity of € 391,364. Compared with financial year 2024, the result moved from € 304,281 to € 288,573. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 26, 2026.

What it is worth Growing

€ 391,364

▲ 281% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 288,573

▼ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 137,274

▲ 159% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 390,364.

People and assets in 2025

Vehicles and equipment

€ 11,201

▼ 70% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 8,145

▼ 99% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 9,106

▼ 45% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 58,547

▲ 155% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 420,018 Gross margin 2022: € 420,018 First fiscal year in the series	€ 444,393 Gross margin 2023: € 444,393 ▲ 6% vs 2022 (€ 420,018) Favourable step	€ 456,583 Gross margin 2024: € 456,583 ▲ 3% vs 2023 (€ 444,393) Favourable step	€ 459,953 Gross margin 2025: € 459,953 ▲ 1% vs 2024 (€ 456,583) Favourable step	▲ 1%
Profit after taxes	€ 283,313 Profit after taxes 2022: € 283,313 First fiscal year in the series	€ 307,741 Profit after taxes 2023: € 307,741 ▲ 9% vs 2022 (€ 283,313) Favourable step	€ 304,281 Profit after taxes 2024: € 304,281 ▼ 1% vs 2023 (€ 307,741) Unfavourable step	€ 288,573 Profit after taxes 2025: € 288,573 ▼ 5% vs 2024 (€ 304,281) Unfavourable step	▼ 5%
Equity	€ 26,110 Equity 2022: € 26,110 First fiscal year in the series	€ 333,851 Equity 2023: € 333,851 ▲ € 307,741 vs 2022 (€ 26,110) Favourable step	€ 102,791 Equity 2024: € 102,791 ▼ 69% vs 2023 (€ 333,851) Unfavourable step	€ 391,364 Equity 2025: € 391,364 ▲ 281% vs 2024 (€ 102,791) Favourable step	▲ 281%
Total debts	€ 1,104,989 Total debts 2022: € 1,104,989 First fiscal year in the series	€ 786,782 Total debts 2023: € 786,782 ▼ 29% vs 2022 (€ 1,104,989) Favourable step	€ 1,072,691 Total debts 2024: € 1,072,691 ▲ 36% vs 2023 (€ 786,782) Unfavourable step	€ 167,968 Total debts 2025: € 167,968 ▼ 84% vs 2024 (€ 1,072,691) Favourable step	▼ 84%
Cash	€ 307,499 Cash 2022: € 307,499 First fiscal year in the series	€ 197,521 Cash 2023: € 197,521 ▼ 36% vs 2022 (€ 307,499) Unfavourable step	€ 53,012 Cash 2024: € 53,012 ▼ 73% vs 2023 (€ 197,521) Unfavourable step	€ 137,274 Cash 2025: € 137,274 ▲ 159% vs 2024 (€ 53,012) Favourable step	▲ 159%
Retained profit	€ 7,510 Retained profit 2022: € 7,510 First fiscal year in the series	€ 315,251 Retained profit 2023: € 315,251 ▲ € 307,741 vs 2022 (€ 7,510) Favourable step	€ 101,791 Retained profit 2024: € 101,791 ▼ 68% vs 2023 (€ 315,251) Unfavourable step	€ 390,364 Retained profit 2025: € 390,364 ▲ 283% vs 2024 (€ 101,791) Favourable step	▲ 283%
Dividend	€ 921,629 Dividend 2022: € 921,629 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 921,629) Unchanged	€ 517,741 Dividend 2024: € 517,741 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 517,741) Unchanged	▼ 100%
Bank debt	€ 80,512 Bank debt 2022: € 80,512 First fiscal year in the series	€ 56,575 Bank debt 2023: € 56,575 ▼ 30% vs 2022 (€ 80,512) Favourable step	€ 737,454 Bank debt 2024: € 737,454 ▲ € 680,879 vs 2023 (€ 56,575) Unfavourable step	€ 8,145 Bank debt 2025: € 8,145 ▼ 99% vs 2024 (€ 737,454) Favourable step	▼ 99%
Balance sheet total	€ 1,131,099 Balance sheet total 2022: € 1,131,099 First fiscal year in the series	€ 1,120,633 Balance sheet total 2023: € 1,120,633 ▼ 1% vs 2022 (€ 1,131,099) Unchanged	€ 1,175,482 Balance sheet total 2024: € 1,175,482 ▲ 5% vs 2023 (€ 1,120,633) Unchanged	€ 559,332 Balance sheet total 2025: € 559,332 ▼ 52% vs 2024 (€ 1,175,482) Unchanged	▼ 52%

Key figures of DR. MANUEL VALCKE - ANESTHESIST, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to DR. MANUEL VALCKE - ANESTHESIST?

What happened at DR. MANUEL VALCKE - ANESTHESIST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 26, 2026 New annual accounts for financial year 2025: profit of € 288,573 (▼ 5% vs 2024). Source: NBB ↗
Mar 1, 2019 New establishment in Sint-Lievens-Houtem. KBO
2019 MANUEL VALCKE became a director. NBB
Mar 1, 2019 Start of the company according to the CBE. KBO

In short

From € 283,313 profit in 2022 to € 288,573 profit in 2025.

Paid € 484,944 in corporate taxes since 2022.

Best year ever: 2023, with € 307,741 profit.

Paid out € 1.4 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. MANUEL VALCKE - ANESTHESIST? We notify you, reason included.

Follow DR. MANUEL VALCKE - ANESTHESIST

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

MANUEL VALCKE

DR. MANUEL VALCKE - ANESTHESIST

CHARLES & THEO

Behind DR. MANUEL VALCKE - ANESTHESIST is MANUEL VALCKE. MANUEL VALCKE is also behind CHARLES & THEO.

See the full network in the app

Directors

According to the 2025 annual accounts

MANUEL VALCKE

Director

Also active at: CHARLES & THEO

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Paardemarkt 21

9520 Sint-Lievens-Houtem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

CHAVENIR TOMA

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0721.753.838
VAT number: BE 0721.753.838
Registered office: Paardemarkt 21, 9520 Sint-Lievens-Houtem
Names & denominations: DR. MANUEL VALCKE - ANESTHESIST
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 March 2019
Peppol: Active · Active since 10 Dec 2024
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗